Daylight
Digital program to reduce worry and anxiety
Company profile
Company profile
Big Health is a digital therapeutics company specializing in mental health solutions that deliver evidence-based cognitive behavioral therapy through fully digital platforms. The company's flagship products include SleepioRx, an FDA-cleared prescription digital therapeutic for chronic insomnia disorder in adults 18+, and DaylightRx, an FDA-cleared treatment for generalized anxiety disorder (GAD) in adults 22+. Both treatments are designed to be used alongside usual care and are reimbursable through insurance. Big Health serves three primary markets: health systems and providers seeking reimbursable, FDA-cleared digital treatments to address patient demand and waitlists; health plans looking to scale access to first-line treatments while reducing costs; and employers aiming to provide employees with instant access to effective mental health care. The company also offers non-prescription workplace solutions including Sleepio for sleep improvement, Daylight for anxiety reduction, and Spark Direct for mood improvement. With over 500,000 patients treated and supported, Big Health's approach is grounded in extensive clinical validation, including 100+ peer-reviewed publications, 22 completed randomized controlled trials, and references in clinical guidelines such as those from the American College of Physicians. The company reports significant patient outcomes: 76% improvement in sleep for insomnia patients, 71% improvement in worry and anxiety, and 67% improvement in mood. Their solutions are HIPAA compliant and HITRUST certified, maintaining a 4+ App Store rating and a 9.8/10 client implementation satisfaction score.
Company description Big Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
FDA clearance for SleepioRx and DaylightRx as prescription digital therapeutics. Achieved reimbursability through insurance with new billing codes. Treated 500,000+ patients.
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Digital program to reduce worry and anxiety
FDA-cleared digital CBT treatment for generalized anxiety disorder
Evidence-based digital program to improve sleep quality
FDA-cleared digital CBT-I treatment for chronic insomnia disorder
Digital program to improve mood and mental health
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Naunyn-Schmiedeberg's archives of pharmacology · Aug 19, 2026
Oridonin loaded amphiphilic hyaluronic acid polymeric micelle with tunable redox sensitive property for CD44 targeted lung cancer therapy.Discover nano · Jul 10, 2026
Comment on "Deep versus moderate neuromuscular blockade on postoperative recovery quality: a systematic review and meta-analysis of randomized controlled trials".Journal of anesthesia · Jul 7, 2026
Preference for the modality of psychosocial treatment for anxiety in adults with comorbid anxiety and chronic musculoskeletal pain.Cognitive behaviour therapy · Jul 1, 2026
Unlocking the Therapeutic Potential of Ganoderma lucidum: From Bioactive Compounds to Clinical Translation.Phytotherapy research : PTR · Jul 1, 2026
Guideline clarification: dropout in FDA-cleared dCBT-I is comparable to pharmacotherapy and therapist-delivered CBT-I.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · Jul 1, 2026
Clinical validation
NCT05511285 · Sponsor · RECRUITING
A Study of Digital Cognitive Behavioural Therapy for Insomnia in FibromyalgiaNCT05962138 · Sponsor · COMPLETED
Perinatal Research on Improving Sleep and Mental HealthNCT05596318 · Mentioned · ACTIVE NOT RECRUITING
Improving Sleep in Rehabilitation After StrokeNCT04272892 · Sponsor · COMPLETED
A Pilot Study of Digital Cognitive Behavioral Therapy for VeteransNCT03688763 · Sponsor · TERMINATED
Frailty Intervention in Postoperative Hip Fracture InpatientsNCT07027241 · Mentioned · NOT YET RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Clinical improvement with no serious side effects
Anxiety patients achieving clinical improvement with no serious side effects
25% improvement in scores on validated screening measure
Cost savings for health plans
Cost savings for health plans
Cost savings for health plans
Managing anxiety as a caregiver
Gained useful coping mechanisms for ongoing anxiety management
Managing anxiety as a recent graduate in a new city
Increased control over anxiety through learned techniques
Managing insomnia and jet lag for frequent travelers
Improved sleep quality through interactive CBT-I treatment
Treating insomnia for anxious individuals
Feeling like herself again after treatment
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Big Health's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.